Morphic Holding, Inc. (MORF) on Tuesday announced the appointment of Simon Cooper as the Chief Medical Officer.
With a background in immunology and inflammatory diseases, Cooper brings extensive expertise as a clinical development leader. Prior to this role, Cooper held the position of Chief Medical Officer at Keros Therapeutics.
For comments and feedback: editorial@rttnews.com